Alfasigma USA Announces ZELNORM™ (tegaserod) Now Available for Treatment of Irritable Bowel Syndrome with Constipation
ZELNORM approved by FDA in March 2019 after thorough safety review Alfasigma USA has begun national reintroduction of ZELNORM to…
Pharmaceuticals, Biotechnology and Life Sciences
ZELNORM approved by FDA in March 2019 after thorough safety review Alfasigma USA has begun national reintroduction of ZELNORM to…
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/guthealth?src=hash" target="_blank"gt;#guthealthlt;/agt;–Gemelli Biotech, in partnership with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, announced…
Allergan has made a deal to get Assembly Biosciences’s microbiome gastrointestinal (GI) development programs which will enable Allergane to use more compounds in researching stomach problems.
4D Pharma’s Blautix, a single strain live biotherapeutic for the treatment of chronic abdomen disorder, Irritable Bowel Syndrome (IBS), has…